Cardiac risk factors and hypoglycemia in an elderly patient: How good is good enough?

Consultant Pharmacist

Volumn 25, Issue SUPPL. B, 2010, Pages 19-27

  Triplitt, Curtis ^a,b  

^a Texas Diabetes Institute   (United States)

^b University of Texas Health Science Center   (United States)

Author keywords

A1C; Cardiovascular disease; Hypoglycemia; Hypoglycemic unawareness; Macrovascular; Microvascular; T2DM; Type 2 diabetes mellitus

Indexed keywords

ACARBOSE; ACETYLSALICYLIC ACID; ATORVASTATIN; BROMOCRIPTINE; COLESEVELAM; DESIPRAMINE; EXENDIN 4; GLIBENCLAMIDE; HEMOGLOBIN A1C; HYDROCHLOROTHIAZIDE; INSULIN; LIRAGLUTIDE; LISINOPRIL; METFORMIN; METOPROLOL; MIGLITOL; NATEGLINIDE; PARACETAMOL; PIOGLITAZONE; PRAMLINTIDE; REPAGLINIDE; ROSIGLITAZONE; SAXAGLIPTIN; SITAGLIPTIN; SULFONYLUREA;

AGED; AGING; BEDTIME DOSAGE; CARDIOVASCULAR RISK; CASE REPORT; DIABETES MELLITUS; EARLY DIAGNOSIS; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; MALE; MEDICAL PRACTICE; MEDICAL RESEARCH; NON INSULIN DEPENDENT DIABETES MELLITUS; PHARMACIST; PRACTICE GUIDELINE; REVIEW; SCREENING TEST;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PHARMACISTS; PRACTICE GUIDELINES AS TOPIC; PROFESSIONAL ROLE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 77953774655     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. American Diabetes Association. Standards of medical care in diabetes - 2009. American Diabetes Association. Diabetes Care 2009;32 Suppl 1:S13-S61.
2. Gerstein HC, Miller ME, Byington RP et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59.
3. Patel A, MacMahon S, Chalmers J et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-72.
4. Duckworth W, Abraira C, Moritz T et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360:129-39.
5. Riddle M. Paper presented at ADA Scientific Sessions, Symposia; New Orleans, LA; 2009.
6. American Diabetes Association. Standards of medical care in Diabetes - 2010. Diabetes Care 2010;33 Suppl 1:S11-S61.
7. Holman RR, Paul SK, Bethel MA et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-89.
8. Nathan DM, Cleary PA, Backlund JY et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-53.
9. Duckworth W. Paper presented at ADA Scientific Sessions, Symposia; New Orleans, LA; 2009.
10. Screening and Management of Hyperglycemia in the Geriatric Population. Texas Department of State Health Services: Texas Diabetes Council. Available at http://www.dshs.state.tx.us/diabetes/PDF/ algorithms/Geriatric%20Hyperglycemia. pdf. Accessed August 19, 2009.
11. Phend C (staff writer). ADA: Still no culprit for excess mortality with tight glucose control. Medpage Today June 10, 2009. Available at http://www.medpagetoday.com/MeetingCoverage/ADA/14635. Accessed January 15, 2010.
12. American Diabetes Association. Standards of medical care in diabetes - 2007. American Diabetes Association. Diabetes Care 2007;30 Suppl 1:S4-S41.
13. Rodbard HW, Blonde L, Braithwaite SS et al. American Association of Clinical Endocrinologist medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007; 13 Suppl 1:S1-S68.
14. Dormandy JA, Charbonnel B, Eckland DJ et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macro Vascular Events): a randomized controlled trial. Lancet 2005;366:1279-89.
15. Home PD, Pocock SJ, Beck-Nielsen H et al. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomized, open-label trial. Lancet 2009;373:2125-35.
16. Nathan DM, Buse JB, Davidson MB et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32:193-203.